156 related articles for article (PubMed ID: 32838606)
1. Ocular findings of albinism in
Ernst J; Alabek ML; Eldib A; Madan-Khetarpal S; Sebastian J; Bhatia A; Liasis A; Nischal KK
Ophthalmic Genet; 2020 Dec; 41(6):650-655. PubMed ID: 32838606
[TBL] [Abstract][Full Text] [Related]
2. Ocular Phenotype Associated with
Méjécase C; Way CM; Owen N; Moosajee M
Genes (Basel); 2021 Feb; 12(2):. PubMed ID: 33562844
[TBL] [Abstract][Full Text] [Related]
3. DYRK1A pathogenic variants in two patients with syndromic intellectual disability and a review of the literature.
Meissner LE; Macnamara EF; D'Souza P; Yang J; Vezina G; ; Ferreira CR; Zein WM; Tifft CJ; Adams DR
Mol Genet Genomic Med; 2020 Dec; 8(12):e1544. PubMed ID: 33159716
[TBL] [Abstract][Full Text] [Related]
4. DYRK1A haploinsufficiency causes a new recognizable syndrome with microcephaly, intellectual disability, speech impairment, and distinct facies.
Ji J; Lee H; Argiropoulos B; Dorrani N; Mann J; Martinez-Agosto JA; Gomez-Ospina N; Gallant N; Bernstein JA; Hudgins L; Slattery L; Isidor B; Le Caignec C; David A; Obersztyn E; Wiśniowiecka-Kowalnik B; Fox M; Deignan JL; Vilain E; Hendricks E; Horton Harr M; Noon SE; Jackson JR; Wilkens A; Mirzaa G; Salamon N; Abramson J; Zackai EH; Krantz I; Innes AM; Nelson SF; Grody WW; Quintero-Rivera F
Eur J Hum Genet; 2015 Nov; 23(11):1473-81. PubMed ID: 25944381
[TBL] [Abstract][Full Text] [Related]
5. Case report of novel DYRK1A mutations in 2 individuals with syndromic intellectual disability and a review of the literature.
Luco SM; Pohl D; Sell E; Wagner JD; Dyment DA; Daoud H
BMC Med Genet; 2016 Feb; 17():15. PubMed ID: 26922654
[TBL] [Abstract][Full Text] [Related]
6. Clinical phenotype of ASD-associated
Earl RK; Turner TN; Mefford HC; Hudac CM; Gerdts J; Eichler EE; Bernier RA
Mol Autism; 2017; 8():54. PubMed ID: 29034068
[TBL] [Abstract][Full Text] [Related]
7. The DYRK1A gene is a cause of syndromic intellectual disability with severe microcephaly and epilepsy.
Courcet JB; Faivre L; Malzac P; Masurel-Paulet A; Lopez E; Callier P; Lambert L; Lemesle M; Thevenon J; Gigot N; Duplomb L; Ragon C; Marle N; Mosca-Boidron AL; Huet F; Philippe C; Moncla A; Thauvin-Robinet C
J Med Genet; 2012 Dec; 49(12):731-6. PubMed ID: 23099646
[TBL] [Abstract][Full Text] [Related]
8. Ten new cases further delineate the syndromic intellectual disability phenotype caused by mutations in DYRK1A.
Bronicki LM; Redin C; Drunat S; Piton A; Lyons M; Passemard S; Baumann C; Faivre L; Thevenon J; Rivière JB; Isidor B; Gan G; Francannet C; Willems M; Gunel M; Jones JR; Gleeson JG; Mandel JL; Stevenson RE; Friez MJ; Aylsworth AS
Eur J Hum Genet; 2015 Nov; 23(11):1482-7. PubMed ID: 25920557
[TBL] [Abstract][Full Text] [Related]
9. DYRK1A-related intellectual disability: a syndrome associated with congenital anomalies of the kidney and urinary tract.
Blackburn ATM; Bekheirnia N; Uma VC; Corkins ME; Xu Y; Rosenfeld JA; Bainbridge MN; Yang Y; Liu P; Madan-Khetarpal S; Delgado MR; Hudgins L; Krantz I; Rodriguez-Buritica D; Wheeler PG; Al-Gazali L; Mohamed Saeed Mohamed Al Shamsi A; Gomez-Ospina N; Chao HT; Mirzaa GM; Scheuerle AE; Kukolich MK; Scaglia F; Eng C; Willsey HR; Braun MC; Lamb DJ; Miller RK; Bekheirnia MR
Genet Med; 2019 Dec; 21(12):2755-2764. PubMed ID: 31263215
[TBL] [Abstract][Full Text] [Related]
10. Generation of a human induced pluripotent stem cell line (FDCHi012-A) from a patient with DYRK1A-related intellectual disability syndrome carrying DYRK1A mutation (c.1024G > T).
Ge Y; Cheng Y; Yin T; Peng X; Xiong Z; Wu B; Wang H; Xiong M; Zhou W
Stem Cell Res; 2024 Apr; 76():103345. PubMed ID: 38382213
[TBL] [Abstract][Full Text] [Related]
11. Characterization of phenotypic range in DYRK1A haploinsufficiency syndrome using standardized behavioral measures.
Fenster R; Ziegler A; Kentros C; Geltzeiler A; Green Snyder L; Brooks E; Chung WK
Am J Med Genet A; 2022 Jul; 188(7):1954-1963. PubMed ID: 35285131
[TBL] [Abstract][Full Text] [Related]
12. DYRK1A mutations in two unrelated patients.
Ruaud L; Mignot C; Guët A; Ohl C; Nava C; Héron D; Keren B; Depienne C; Benoit V; Maystadt I; Lederer D; Amsallem D; Piard J
Eur J Med Genet; 2015 Mar; 58(3):168-74. PubMed ID: 25641759
[TBL] [Abstract][Full Text] [Related]
13. Disruptive de novo mutations of DYRK1A lead to a syndromic form of autism and ID.
van Bon BW; Coe BP; Bernier R; Green C; Gerdts J; Witherspoon K; Kleefstra T; Willemsen MH; Kumar R; Bosco P; Fichera M; Li D; Amaral D; Cristofoli F; Peeters H; Haan E; Romano C; Mefford HC; Scheffer I; Gecz J; de Vries BB; Eichler EE
Mol Psychiatry; 2016 Jan; 21(1):126-32. PubMed ID: 25707398
[TBL] [Abstract][Full Text] [Related]
14. Tregs and Th17 lymphocytes in human DYRK1A haploinsufficiency.
Valencic E; Piscianz E; Sirchia F; Tommasini A; Faletra F; Todaro F; Spinelli AM; Badolato R
Immunol Lett; 2019 Oct; 214():52-54. PubMed ID: 31442541
[No Abstract] [Full Text] [Related]
15. Integrative approach to interpret DYRK1A variants, leading to a frequent neurodevelopmental disorder.
Courraud J; Chater-Diehl E; Durand B; Vincent M; Del Mar Muniz Moreno M; Boujelbene I; Drouot N; Genschik L; Schaefer E; Nizon M; Gerard B; Abramowicz M; Cogné B; Bronicki L; Burglen L; Barth M; Charles P; Colin E; Coubes C; David A; Delobel B; Demurger F; Passemard S; Denommé AS; Faivre L; Feger C; Fradin M; Francannet C; Genevieve D; Goldenberg A; Guerrot AM; Isidor B; Johannesen KM; Keren B; Kibæk M; Kuentz P; Mathieu-Dramard M; Demeer B; Metreau J; Steensbjerre Møller R; Moutton S; Pasquier L; Pilekær Sørensen K; Perrin L; Renaud M; Saugier P; Rio M; Svane J; Thevenon J; Tran Mau Them F; Tronhjem CE; Vitobello A; Layet V; Auvin S; Khachnaoui K; Birling MC; Drunat S; Bayat A; Dubourg C; El Chehadeh S; Fagerberg C; Mignot C; Guipponi M; Bienvenu T; Herault Y; Thompson J; Willems M; Mandel JL; Weksberg R; Piton A
Genet Med; 2021 Nov; 23(11):2150-2159. PubMed ID: 34345024
[TBL] [Abstract][Full Text] [Related]
16. Whole genome sequencing of 45 Japanese patients with intellectual disability.
Abe-Hatano C; Iida A; Kosugi S; Momozawa Y; Terao C; Ishikawa K; Okubo M; Hachiya Y; Nishida H; Nakamura K; Miyata R; Murakami C; Takahashi K; Hoshino K; Sakamoto H; Ohta S; Kubota M; Takeshita E; Ishiyama A; Nakagawa E; Sasaki M; Kato M; Matsumoto N; Kamatani Y; Kubo M; Takahashi Y; Natsume J; Inoue K; Goto YI
Am J Med Genet A; 2021 May; 185(5):1468-1480. PubMed ID: 33624935
[TBL] [Abstract][Full Text] [Related]
17. Structural analysis of pathogenic mutations in the DYRK1A gene in patients with developmental disorders.
Evers JM; Laskowski RA; Bertolli M; Clayton-Smith J; Deshpande C; Eason J; Elmslie F; Flinter F; Gardiner C; Hurst JA; Kingston H; Kini U; Lampe AK; Lim D; Male A; Naik S; Parker MJ; Price S; Robert L; Sarkar A; Straub V; Woods G; Thornton JM; ; Wright CF
Hum Mol Genet; 2017 Feb; 26(3):519-526. PubMed ID: 28053047
[TBL] [Abstract][Full Text] [Related]
18. Zebrafish knockout of Down syndrome gene,
Kim OH; Cho HJ; Han E; Hong TI; Ariyasiri K; Choi JH; Hwang KS; Jeong YM; Yang SY; Yu K; Park DS; Oh HW; Davis EE; Schwartz CE; Lee JS; Kim HG; Kim CH
Mol Autism; 2017; 8():50. PubMed ID: 29021890
[TBL] [Abstract][Full Text] [Related]
19. Case report: A novel
Zhou C; Zhu H; Xiang Q; Mai J; Wang X; Wang J; Liu S
Front Neurosci; 2023; 17():1174925. PubMed ID: 37274198
[TBL] [Abstract][Full Text] [Related]
20. Rock around DYRK1A: Ethnic diversity, clinical challenges.
Moroni A; Pezzani L; Alfei E; Scatigno A; Cereda A; Marzaroli M; Guuva C; Gabbiadini S; Pezzoli L; Marchetti D; Spaccini L; Iascone M
Am J Med Genet A; 2023 May; 191(5):1459-1464. PubMed ID: 36772973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
